These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6089553)

  • 1. Converting enzyme inhibition for understanding and management of hypertensive disorders and congestive heart failure. Symposium, Anaheim, California, November 13, 1983.
    Am J Med; 1984 Aug; 77(2A):1-86. PubMed ID: 6089553
    [No Abstract]   [Full Text] [Related]  

  • 2. Converting enzyme inhibition in hypertension and congestive heart failure. Rotterdam, The Netherlands, March 16, 1985.
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S1-70. PubMed ID: 2422486
    [No Abstract]   [Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibitors in hypertension and congestive heart failure.
    Gavras I; Gavras H
    Adv Intern Med; 1990; 35():249-67. PubMed ID: 2405595
    [No Abstract]   [Full Text] [Related]  

  • 4. Introduction to the symposium on practical aspects of angiotensin-converting enzyme inhibition.
    Chilton RJ
    J Am Osteopath Assoc; 1987 Feb; 87(2 Suppl):164-5. PubMed ID: 3030976
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibitors in congestive heart failure.
    Norcross WA
    West J Med; 1995 Jul; 163(1):67. PubMed ID: 7667987
    [No Abstract]   [Full Text] [Related]  

  • 6. A new angiotensin-converting enzyme inhibitor: treatment of hypertension and congestive heart failure. Proceedings of an international symposium on enalapril, sponsored by Merck Sharp & Dohme International, São Paulo, Brazil, November 10, 1984.
    Drugs; 1985; 30 Suppl 1():1-96. PubMed ID: 2994983
    [No Abstract]   [Full Text] [Related]  

  • 7. Does aspirin interfere with the therapeutic efficacy of angiotensin-converting enzyme inhibitors in hypertension or congestive heart failure?
    Nawarskas JJ; Spinler SA
    Pharmacotherapy; 1998; 18(5):1041-52. PubMed ID: 9758314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The practical aspects of combination therapy with angiotensin receptor blockers and angiotensin-converting enzyme inhibitors.
    Sica DA
    J Renin Angiotensin Aldosterone Syst; 2002 Jun; 3(2):66-71. PubMed ID: 12228845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibitors and end-organ damage in heart failure.
    Sami M
    Can J Cardiol; 1999 May; 15 Suppl C():19C-23C. PubMed ID: 10380688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin converting enzyme inhibition in the management of congestive heart failure.
    McClure RR
    J Ky Med Assoc; 1988 Jan; 86(1):17-9. PubMed ID: 3278064
    [No Abstract]   [Full Text] [Related]  

  • 11. ACE-inhibition: state of the art. Symposium held during the Xth Congress of the European Society of Cardiology. Vienna, August 31, 1988. Proceedings.
    Cardiology; 1989; 76 Suppl 2():1-68. PubMed ID: 2766310
    [No Abstract]   [Full Text] [Related]  

  • 12. [Renal side effects of angiotensin converting enzyme inhibitors].
    Schmidt A; Mayer G
    Wien Med Wochenschr; 1996; 146(16):454-6. PubMed ID: 9036683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiovascular pharmacology (IX). Angiotensin-converting enzyme inhibitors in hypertension and heart failure].
    de Teresa E; Espinosa JS; Gómez Doblas JJ
    Rev Esp Cardiol; 1995 Feb; 48(2):128-41. PubMed ID: 7886264
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparison between the effects of angiotensin-converting enzyme inhibitors and angiotensin II antagonists].
    Asmar R; Madonna O; Brisac AM; Benetos A; Laurent S
    Therapie; 1998; 53(3):253-70. PubMed ID: 9773125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinctive properties of perindopril among converting enzyme inhibitors in congestive heart failure.
    Sami MH
    Can J Cardiol; 1994 Nov; 10 Suppl D():13D-16D. PubMed ID: 7954033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A three year clinical review of the impact of angiotensin converting enzyme inhibitors on the intra hospital mortality of congestive heart failure in Nigerians.
    Adewole AD; Ikem RT; Adigun AQ; Akintomide AO; Balogun MO; Ajayi AA
    Cent Afr J Med; 1996 Aug; 42(8):253-5. PubMed ID: 8990572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symposium: Converting enzyme inhibition. New trends in the treatment of hypertension and congestive heart failure. Brussels, Belgium, June 21, 1985.
    Acta Cardiol; 1986; 41(5):329-96. PubMed ID: 3022508
    [No Abstract]   [Full Text] [Related]  

  • 18. ACE inhibitors: review of four new agents.
    Binder SB
    Am Fam Physician; 1993 Oct; 48(5):851-7. PubMed ID: 8213415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding ACE inhibitors.
    Wilson BA
    Medsurg Nurs; 1995 Feb; 4(1):62-4. PubMed ID: 7874224
    [No Abstract]   [Full Text] [Related]  

  • 20. Symposium on angiotensin-converting enzyme inhibition in cardiac failure. Oslo, 23 October 1985. Proceedings.
    Drugs; 1986; 32 Suppl 5():1-53. PubMed ID: 3032560
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.